Experiences with a three step test scheme for embryotoxicity and teratogenicity.
Experiences with the three step teratological screening test for selection of teratogenic side effects are described. Step I: The prenatal examination of the foetuses may give indications of embryotoxicity, growth retardation and teratogenicity. Step II: The peri- and postnatal examination includes the duration of pregnancy, the delivery, the viability, the postnatal development and behaviour of the untreated offspring. In special cases the transplacental tumour induction may be studied. Step III: The fertility of the untreated offspring is examined and, in some cases, the generation test should be added.
D000014:Abnormalities, Drug-Induced / Q000473:pathology; D000818:Animals; D004622:Embryo, Mammalian / Q000187:drug effects*; D004625:Embryo, Nonmammalian; D005260:Female; D005298:Fertility / Q000187:drug effects; D006128:Growth / Q000187:drug effects; D011247:Pregnancy; D013723:Teratogens / Q000633:toxicity*
D013723:Teratogens